Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports

BACKGROUND: Vaccination remains the cornerstone approach to exiting the current global coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus 2. The novel messenger ribonucleic acid vaccines offer a high level of protection and are widely used throughout the world....

Descripción completa

Detalles Bibliográficos
Autores principales: Vutipongsatorn, Kritchai, Isaacs, Anthony, Farah, Ziad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801240/
https://www.ncbi.nlm.nih.gov/pubmed/35094715
http://dx.doi.org/10.1186/s13256-022-03266-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801240/
https://www.ncbi.nlm.nih.gov/pubmed/35094715
http://dx.doi.org/10.1186/s13256-022-03266-1

Ejemplares similares